COYA
Coya Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.89
+2.73%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.35
- Revenue estimate
- $110.0K
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.28
- EPS estimate
- -$0.35
- Revenue actual
- $221.9K
- Revenue estimate
- $130.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -147.0%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $14
- PT range
- $12 – $16
- Analysts
- 3
3 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.35 | -$0.28 | Beat 19.01% | $221.9K |
| May 12, 2026 | -$0.39 | -$0.32 | Beat 17.95% | $300.0K |
| Mar 16, 2026 | -$0.27 | -$0.34 | Miss -24.77% | $4.0M |
| Nov 12, 2025 | $0.02 | -$0.10 | Miss -600.00% | $3.6M |
| Aug 12, 2025 | -$0.22 | -$0.36 | Miss -63.64% | $163.6K |
| Mar 18, 2025 | -$0.26 | -$0.18 | Beat 30.77% | — |
| May 9, 2024 | -$0.30 | -$0.35 | Miss -16.67% | $126.8K |
| Mar 19, 2024 | $0.26 | $0.15 | Miss -42.31% | $6.0M |
| Sep 30, 2022 | — | -$0.42 | — | — |
| Mar 31, 2022 | — | -$0.26 | — | — |
| Dec 31, 2021 | — | -$0.25 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026